Basic Information
| LncRNA/CircRNA Name | AC010761.9 |
| Synonyms | NA |
| Region | GRCh38_17:28732963-28743102 |
| Ensemble | ENSG00000265073 |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | gastric adenocarcinoma |
| ICD-0-3 | C16 |
| Methods | Microarray, qPCR etc. |
| Sample | GA tissues, cell lines (MGC803, BGC823, and SGC7901) |
| Expression Pattern | up-regulated |
| Function Description | AC010761.9 was related to tumor size, degree of differentiation , and serum carbohydrate antigen (and carcinoembryonic antigen (CEA) concentrations. Multivariate analysis further confirmed that the expression of lncRNA AC010761.9 was related to the degree of tumor differentiation. Additionally, the expression of lncRNA AC010761.9 had a positive correlation with the mRNA expression of the potentially associated gene (TRAF4) in GA tissues .LncRNA AC010761.9 may be linked to GA progression and is a potential new biomarker for GA. |
| Pubmed ID | 29499718 |
| Year | 2018 |
| Title | Evaluation of the expression and clinical value of lncRNA AC010761.9 in human gastric adenocarcinoma. |
External Links
| Links for AC010761.9 | GenBank HGNC NONCODE |
| Links for gastric adenocarcinoma | OMIM COSMIC |